HEI Civil Announces Appointment of JP Morgan to Chief Operating Officer
12. November 2024 12:00 ET
|
HEI Civil
CASTLE ROCK, Colo., Nov. 12, 2024 (GLOBE NEWSWIRE) -- HEI Civil, a national heavy civil construction company, is pleased to announce the promotion of JP Morgan to Chief Operating Officer. Morgan...
Recursion to Participate in Upcoming Investor Conferences
03. Juni 2024 09:00 ET
|
Recursion Pharmaceuticals
SALT LAKE CITY, June 03, 2024 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced its...
Recursion to Participate in Upcoming Investor Conferences
01. Mai 2024 08:01 ET
|
Recursion Pharmaceuticals
SALT LAKE CITY, May 01, 2024 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced its...
CSX Chief Executive Officer to Address JP Morgan Industrials Conference
06. März 2024 10:00 ET
|
CSX Corporation
JACKSONVILLE, Fla., March 06, 2024 (GLOBE NEWSWIRE) -- CSX Corp. (NASDAQ: CSX) President and Chief Executive Officer, Joe Hinrichs, will address the 2024 JP Morgan Industrials Conference in New York...
Pacific General Appoints Pieter Wernink and John Romney as Senior Advisors
25. Januar 2024 08:57 ET
|
Pacific General
Pacific General, announces the appointment of Pieter Wernick and John Romney as Senior Advisors to Pacific General’s Private Equity team.
Recursion Unveils LOWE Drug Discovery Software at the J.P. Morgan Healthcare Conference
08. Januar 2024 10:59 ET
|
Recursion Pharmaceuticals
SAN FRANCISCO, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today presented a demonstration...
Citeline to Share Exclusive Insights from 42nd Annual J.P. Morgan Healthcare Conference
08. Januar 2024 09:00 ET
|
Citeline
Citeline, a Norstella company, will provide exclusive access, including daily insights, to the 42nd Annual J.P. Morgan Healthcare Conference Jan. 8-11.
AVITA Medical to Present at the 42nd Annual J.P. Morgan Healthcare Conference
04. Januar 2024 09:00 ET
|
AVITA Medical
AVITA Medical to present at JP Morgan's Annual Healthcare Conference in San Francisco on Thursday, January 11, 2024.
Revolution Medicines to Present at 42nd Annual J.P. Morgan Healthcare Conference
04. Januar 2024 07:00 ET
|
Revolution Medicines, Inc.
REDWOOD CITY, Calif., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for RAS-addicted cancers, today...
Privia Health to Participate in the J.P. Morgan Healthcare Conference
12. Dezember 2023 09:00 ET
|
Privia Health Group, Inc.
Privia Health (Nasdaq: PRVA) will present at the J.P. Morgan HC Conference on Monday, January 8, 2024, beginning at 6:45 pm ET / 3:45 pm PT